3,3',5-triiodothyronamine has been researched along with cuprizone in 1 studies
| Studies (3,3',5-triiodothyronamine) | Trials (3,3',5-triiodothyronamine) | Recent Studies (post-2010) (3,3',5-triiodothyronamine) | Studies (cuprizone) | Trials (cuprizone) | Recent Studies (post-2010) (cuprizone) |
|---|---|---|---|---|---|
| 26 | 1 | 8 | 825 | 1 | 629 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franco, PG; Pasquini, JM; Silvestroff, L; Soto, EF | 1 |
1 other study(ies) available for 3,3',5-triiodothyronamine and cuprizone
| Article | Year |
|---|---|
Thyroid hormones promote differentiation of oligodendrocyte progenitor cells and improve remyelination after cuprizone-induced demyelination.
Topics: Animals; Animals, Newborn; Antigens; Blood Coagulation Factors; Cell Differentiation; Cuprizone; Demyelinating Diseases; Gangliosides; Glial Fibrillary Acidic Protein; Hedgehog Proteins; Myelin Basic Protein; O Antigens; Oligodendroglia; Proteoglycans; Rats; Rats, Wistar; Receptor-Interacting Protein Serine-Threonine Kinases; Receptors, Cell Surface; Stem Cells; Thyroid Hormones; Time Factors; Triiodothyronine | 2008 |